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Background: Intercellular adhesion molecule-1 (ICAM-1) and E-selectin have been shown 
to predict cardiovascular disease (CVD) such as myocardial infarction, stroke, and peripheral 
arterial occlusive disease (PAOD).
Methods: Two mutations, S128R in E-selectin and K469E in ICAM-1, were investigated in 
156 patients with PAOD and 100 control subjects using polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) analysis in an Egyptian population.
Results: The distribution of E-selectin genotypes in patients affected by PAOD was 84.6% for 
the AA genotype and 15.4% for the AC genotype. In the control arm the distribution was 97% 
for the AA genotype and 3% for the AC genotype. There was a statistically significance differ-
ence in the distribution of the AC genotype in PAOD patients when compared with the control 
subjects. Additionally, the distribution of ICAM-1 genotypes in patients affected by PAOD was 
30.8% with the EE, 48% with the EK, and 21.2% with the KK genotypes. The distribution of 
ICAM-1 genotypes in control subjects was 13% EE, 33% EK and 54% KK. The EE genotype 
was significantly more common in PAOD patients than in the controls.
Conclusion: S128R and K469E polymorphisms were associated with increased risk in PAOD. 
Early detection of these polymorphic genes helps in early prophylaxis against PAOD.
Keywords: polymorphism, PAOD, E-selectin, ICAM-1, RFLP, genotyping
Introduction
Patients with peripheral arterial occlusive disease (PAOD) show persistently high 
morbidity and mortality rates. Treatment entails revascularization (by open surgery 
or endovascular interventions), amputation and medical treatment that includes the 
modification of risk factors associated with the disease. Inflammation plays a role in 
the pathogenesis of atherosclerosis and PAOD.1
Various inflammatory mediators such as tumor necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and bacterial lipopolysaccharide (LPS), increase the expres-
sion of cell adhesion molecules (CAMs) including intercellular adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin on endothelial 
cells.2 Thus, upon inflammatory stimulation, the endothelial barrier function is rapidly 
lost and preformed P-selectin is translocated to the luminal surface of endothelial cells, 
followed by expression and release of E-selectin, ICAM-1, and VCAM-1 – substances 
that regulate the attachment and trans-endothelial migration of leukocytes. Both macro-
phages and endothelial cells produce ICAM-1 in response to inflammatory cytokines.3 
Circulating markers of systemic inflammation such as C-reactive protein (CRP), IL-6, 
ICAM-1, and E-selectin have been shown to predict the increased probability of future Vascular Health and Risk Management 2010:6 10
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cardiovascular disease (CVD), such as myocardial infarction, 
stroke, and PAOD.4
The S128R polymorphism of the E-selectin gene is of 
interest for two reasons: first, it is overrepresented in certain 
patient groups affected by disease that is characterized by an 
increased adhesiveness of leukocytes to the endothelium; 
such as atherosclerosis and myocardial infarction and 
secondly, it is a functional polymorphism since it modi-
fies ligand affinity.5,6 This mutation confers an alteration in 
selectin ligand-binding specificity which leads to a gain of 
function under flow conditions, possibly amplifying the 
number of leukocytes that roll and subsequently adhere to 
the endothelium.7 Furthermore, S128R transduced endothelial 
cells support significantly more rolling and adhesion of 
neutrophils and mononuclear cells compared to epithelial 
cells (EC)s transduced with wild-type E-selectin.8 Substi-
tution of the E-selectin epidermal growth factor domain 
residue Ser128 with an arginine residue results in E-selectin 
proteins that have lost the requirement for alpha1–3-linked 
fucose and are thus able to bind to sialyllactosamine. These 
S128R-transduced ECs also exhibit significantly greater levels 
of phosphorylation of extracellular signal-regulated kinases 1 
and 2 together with p38 mitogen-activated protein kinase. 
This suggests that an altered endothelial signaling pathway 
is associated with this polymorphism.9
ICAM-1 plays a major role in leukocyte infiltration as 
well as T cell activation by B cells. The human ICAM-1 
gene is located on chromosome 19p13.3–p13.2 and contains 
seven exons. Several single-nucleotide polymorphisms 
(SNPs) of the human ICAM-1 gene have been reported, and 
functional analyses regarding the association between each 
polymorphism and certain diseases have been performed.10 
Two ICAM-1, coding region, biallelic polymorphisms have 
been identified: Gly (G) or Arg (R) at codon 241 (exon 4) and 
Lys (K) or Glu (E) at codon 469 (exon 6).11 E469K is known 
to be common in all populations and has been analyzed for 
its association with several inflammatory diseases.12 Our 
aim was to evaluate the association between gene polymor-
phism of E-selectin and ICAM and PAOD in an Egyptian 
population.
Subjects and methods
This study was conducted on 256 Egyptian subjects. They 
were divided into two groups: a test group of 156 patients 
suffering from PAOD (78 males and 78 females) and a control 
group that included, 100 age-matched, healthy subjects 
(48 males and 52 females). The patients were subdivided 
into two subgroups: 93 diabetic patients with type II diabetes 
mellitus (DM) and 63 nondiabetic patients (NDM). Patients 
with PAOD were diagnosed by the presence of intermittent 
claudications, rest pain, and/or tissue loss in the absence 
of distal pulsations. Duplex examination was done for all 
patients to confirm the site of arterial occlusion and the 
presence of distal run off. Patients were referred from 
the vascular surgery departments of a number of centers 
to the Kasr El-Aini Hospital between April 2007 and 
December 2008. Healthy individuals, recruited consecutively 
among physicians and coworkers, represented healthy, normal 
control subjects. Comprehensive informed consents were 
obtained from all participants included in the study.
Subject inclusion criteria
Subjects were Egyptian nationals with PAOD at Fontaine’s 
stage II, III, or IV, detected by a detailed history, thorough 
physical and clinical examination together with labora-
tory investigation. Demographic data, a detailed history 
and thorough clinical examination with special emphasis 
on vascular complications was undertaken for both study 
groups. Arterial duplex was performed and the sites of 
occlusion in every PAOD patient were recorded. Appropriate 
treatment was then undertaken according to patients’ pre-
sentation, general condition, and state of distal run off. 
The choice between revascularization by open surgery or 
endovascular intervention was determined by the TASC II 
classification.1
Routine biochemical tests were performed for all groups 
and included: Fasting blood glucose, creatinine, urea, lipid 
profile, alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST). Molecular biology techniques for 
genotyping of E-selectin and ICAM-1 on peripheral blood 
were also undertaken.
Molecular biology techniques
DnA extraction
DNA was extracted from whole blood using QIA amplifica-
tion kit (Qiagen Inc, Valencia, CA, USA). The DNA concen-
tration was determined by measuring the OD at 260 nm.
Primer sequences
The two primers used for genotyping of E-selectin (S128R) 
were designed using Primer 3 software (Primer 3.cgi,V0.2b, 
Whitehead Institute/MIT Center for Genome Research, 
Cambridge, MA, USA) based on the published human CD 
62E genomic DNA sequence flanking the exon 4. Also, two 
primers were used for detection of ICAM (K469E) allelic 
polymorphisms are given in Table 1.Vascular Health and Risk Management 2010:6 11
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genotyping of e-selectin
Detection of the S128R polymorphism was carried out by PCR 
amplification followed by Pst I restriction enzyme digestion.13 
After digestion, the fragment length of the CC genotype was 
357 bp; the fragment lengths of the AA genotype are 219 and 
138 bp; the fragment lengths of the AC genotype are 357, 
219, and 138 bp (Figure 1a).
genotyping of icAM-1
The K469E polymorphism was amplified using two specific 
primers. The polymerase chain reaction (PCR) products were 
identified by enzyme digestion with BstUI which cuts the 
E469 allele but not K469.14 The fragment length of the KK, 
EE and KE genotypes were 223 bp; 136 and 87 bp; 223, 136, 
and 87 bp, respectively (Figure 1b).
Statistical analysis
The statistical analysis was undertaken using SPSS software 
(version 17; SPSS Inc., Chicago, IL, USA). Descriptive 
statistics in form of mean and standard deviation for 
parametric data were used, while frequency and percentage 
were used to describe nonparametric data. ANOVA followed 
by a post-hoc test (Scheffe) were used for comparison of 
parametric data among the test groups. For genotype of the 
E-selectin and ICAM, the differences in their frequency 
were analyzed by the chi-squared test. An unpaired t-test 
was undertaken for comparison of parametric data between 
the different genotypes of E-selectin.
Results
The demographic data of all the studied groups are illustrated 
in Table 2. With regards to the risk factors of smoking, 
hypertension, and ischemic heart disease (IHD), there was a 
statistically significant difference between the control group 
and the patient groups. There was also a statistically signifi-
cant difference between the diabetic arm and the nondiabetic 
arm of the patient group regarding smoking, hypertension 
and cerebrovascular diseases.
The distribution of the site of the lesion revealed 45% of 
the patients had superficial femoral artery occlusion, 24% 
had infrapopliteal occlusion, and 12% had iliac occlusion. 
Infrapopliteal disease was more prevalent in diabetic patients 
(32%). Table 3 shows a detailed distribution of the site of 
arterial occlusion.
Table 1 The sequence of primers
Primer Sequences Product 
size
e-selectin  
(sense)
5′ATggcAcTcTgTAggAcTgcT3′ 357 bp
e-selectin  
(antisense)
5'gTcTcAgcTcAcgATcAccAT3′
icAM-1  
(sense)
5′-ggAAcccATTgcccgAgc-3′ 223 bp
icAM-1 
(antisense)
5′-ggTgAggATTgcATTAggTc-3′
Abbreviation: icAM-1, intercellular adhesion molecule-1.
Figure 1a    Agarore gel electrophoresis 1.5% stained with ethidium bromide showing the e-selectin DnA product after digestion with Psti. Lanes M: DnA marker. Lanes 1, 2: 
AA allelic polymorphism. Lane 3:   Ac allelic polymorphism. Lane 4: negative control.
357 bp
219 bp
138 bp
M M 1 2 3 4
223 bp
136 bp
87 bp
1 2 3 4 5 6 7 8 9 10 11 M
Figure 1b    Agarose gel electrophorsis 2.5% stained with ethidium bromide showing the icAM-1 DnA product after digestion with BstUi. Lanes 1, 2, 5, 10: eK allelic polymor-
phism. Lanes 3, 6-9:  KK allelic polymorphism. Lanes 4, 11: ee allelic polymorphism.Vascular Health and Risk Management 2010:6 12
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There was no statistically significant (P  0.05) difference 
between the control group and the patient groups, concern-
ing any family history of the same condition (PAOD). With 
respect to the family history of both diabetes mellitus and 
hypertension, there was a statistically significant difference 
between the control group and NDM patients versus patients 
with diabetes. However, there was no statistical significance 
difference between the control group and the NDM patients.
The mean values of the laboratory analyses of blood from 
both the patients and control groups are given in Table 4.
Genotypes and single allele polymorphism of E-selectin 
are illustrated in Table 5a. The frequency of AA genotype 
was higher in the control subjects (97%) as compared to all 
in the patient group. The presence of the AA genotype the 
whole patient group (TPG), the DM patients, and NDM 
patients was 84.6%, 87%, and 81% respectively. However, 
there was no statistically significant difference between 
the control subjects when compared to all patient groups 
(P  0.05).
The AC genotype occurred in 3% of the control subjects. 
However, it was detected in 15.4% of the TPG, split between 
the DM patients (13%) and the NDM patients (19%). 
A statistically significant difference (P  0.05) was found 
between the control subjects and all patient groups; TPG, 
DM, and NDM. The frequency of the A allele was higher in 
control group when compared to all the patient groups. The 
frequency of C allele was higher in NDM patients (9.6%), 
TPG patients (7.7%), and DM patients (6.5%) compared to 
the control group (1.5%). There was no statistically significant 
difference between the different groups regarding allele A 
although there was between the different groups regarding 
allele C. There were no statistically significant differences 
between diabetic group and nondiabetic group regarding the 
E-selectin genotypes and E-selectin allele.
Distribution of genotype and single allele of ICAM-1 
in all groups is given in Table 5b. The frequency of the EE 
and EK genotypes was significantly lower (P  0.05) in the 
control subjects than in the TPG, DM, and NDM patients. 
The frequency of KK genotype was significantly higher in 
control subjects (53%) when compared to the patient groups. 
It was 21.2%, 22.6%, and 19% in the TPG, DM, and NDM 
patients respectively.
Table 2 The demographic data of all studied groups
Variables Groups
Control (n = 100) TPG (n = 156) DM (n = 3) NDM (n = 63)
Age (years) 62.4 ± 7.6 59.3 ± 10.7 a 57.8 ± 8.9 a 61.6 ± 12.6 a
Male 47 (47%) 86 (52.1%) 53 (57%) 33 (52.4%)
Female 53 (5.3%) a 70 (47.9%) a 40 (43%) a 30 (47.6%) a
Risk factors
Smokers 47 (47%) a 86 (52.1%) b 53 (57%) bc 33 (52.4%) bd
Hypertensive 20 (20%) a 69 (44.2%) b 57 (61.3%) b 12 (19.%) a
iHD 0 (0%) a 36 (23%) b 27 (29%) b 9 (14.3%) b
cVD 0 (0%) a 18 (11.5%) b 15 (16.2%) b 3 (4.8%) ab
Family history
PAOD 0 (0%) a 3 (2%) a 0 (0%) a 3 (4.8%) a
DM 6 (6%) a 60 (38.5%) b 17 (54.8%) b 9 (14.3%) a
Hypertension 5 (5%) a 27 (17.4%) b 27 (29.%) b 3 (4.8%) a
Notes: The different letter designations, a–d, indicate significant difference between the variables (P  0.05).
Abbreviations: iHD, ischemic heart disease; cVD, cerebrovascular disease; PAOD, peripheral arterial occlusive disease;   TPg, total patient group; DM, diabetes mellitus; 
nDM, nondiabetes mellitus.
Table 3 Frequency distribution of sites of occlusion for all 
patients
Site of occlusions Frequency
   TPG  
(231)
DM  
(141 sites)
NDM  
(0 sites)
common iliac artery 18 (7.8%) 6 (4.3%) 4 (13.3%)
external iliac artery 9 (3.9%) 3 (2.1%) 2 (6.7%)
Popliteal 42 (18.1%) 24 (17%) 6 (20%)
SFA 105 (45.5%)* 63 (44.7%)* 14 (46.7%)*
Posterior tibial 27 (11.7%) 21 (14.9%) 2 (6.7%)
Anterior tibial 12 (5.2%) 12 (8.5%) –
Tiboperoneoal 12 (5.2%) 12 (8.5%) –
Dorsalis pedis 6 (2.6%) – 2 (6.6%)
Note: *Significant at (P  0.05).
Abbreviations: TPg, total patient group; DM, diabetes mellitus; nDM, nondiabetes 
mellitus; SFA, superficial femoral artery.Vascular Health and Risk Management 2010:6 13
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As regards the frequency of K-allele, it was significantly 
higher (P  0.01) in control group when compared to all 
patient groups. While the frequency of the E-allele was 
significantly lower in control group compared to patient 
groups. There was no statistically significant difference 
between the DM and NDM groups regarding both the 
ICAM-1 genotypes and ICAM-1 alleles.
With respect to the laboratory analyses there were no 
statistically significant differences between the labora-
tory data and the different genotypes of ICAM-1 and 
E-selectin.
The total sites of occlusion for all patients were 231 
sites; 141 for 39 of the DM patients, and 90 sites for 
24 of the NDM patients. There was no statistical signifi-
cant difference for sites of occlusion between the DM and 
NDM patients. The incidence of superficial femoral artery 
(SFA) occlusion in the TPG, DM, and NDM groups was 
45.5%, 44.7%, and 46.7%, respectively. The occurrence of 
AA and AC polymorphism in patients presenting with SFA 
were determined as 43.8% and 53.9%, respectively. There 
was no statistically significant difference between patients 
having AA and AC genotype regarding the different sites 
of occlusion. With regard to the ICAM-1 genotypes, the 
most common site of occlusion was also the SFA. It was 
concomitant with 40.7%, 61.1%, and 40.6% of the EE, KK, 
and EK genotypes respectively. There was no statistical 
significance among different groups of patients regarding 
other sites of occlusion.
Discussion
The present study found a statistically significant difference 
(P  0.05) between the control group and TPG patients 
regarding the risk factors for atherosclerosis such as smoking 
and hypertension. Similar results were obtained by both 
Gaetani and colleagues and Hattori and colleagues.14,15 while 
Schgoer and colleagues and Mueller and colleagues16,17 found 
Table 4 Laboratory data of all studied groups as mean ± SD
Variables Groups
  Control (n = 100) TPG (n = 156) DM (n = 3) NDM (n = 63)
FBS (mg/dL) 91.7 ± 11.2 a 176.2 ± 97.4 c 227.8 ± 96.3 b 100 ± 9.7 a
cholesterol (mg/dL) 170 ± 16.3 a 189.8 ± 55.4 a 201.7 ± 61.7 b 172.3 ± 39.6 a
Triglyceride (mg/dL) 95 ± 25.4 a 135.2 ± 76.6 b 142.6 ± 81 b 124.2 ± 70 b
HDL (mg/dL) 62.3 ± 19.4 a 39.7 ± 5.4 b 40.3 ± 59 b 38.8 ± 45 b
LDL (mg/dL) 88. 5 ± 28.3 a 123.7 ± 50.5 b 132.8 ± 56.8 b 110 ± 36.5 b
creatinine (mg/dL) 1 ± 0.3 a 1 ± 0.3 a 0.98 ± 0.3 a 1 ± 0.3 a
Urea (mg/dL) 40 ± 9.7 a 37.3 ± 9.2 a 38.8 ± 9.8 a 34.9 ± 7.9 a
AST (iU/L) 21.2 ± 6.2 a 24.8 ± 9 a 25.2 ± 8.9 a 24.1 ± 9.5 a
ALT (iU/L) 20.9 ± 6.2 a 22.9 ± 10.3 a 21.5 ± 9.2 a 24.9 ± 10.8 a
Hb (g/dL) 12.6 ± 0.8 a 12.6 ± 1.3 a 12.1 ± 1.3 a 12.8 ± 1.5 a
Notes: Different symbols indicate significance. Significant values when P  0.05.
Abbreviations: TPg, total patient group; DM, diabetes mellitus; nDM, nondiabetes mellitus; FBS, fasting blood sugar; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein;   ALT, alanine aminotransferase;   ASDT, aspartate aminotransferase; Hb, hemaglobin; SD, standard deviation.
Table 5a genotypes and alleles of e-selectin among all groups
Variables Groups
  Control (n = 100) TPG (n = 156) DM (n = 3) NDM (n = 63)
E-selectin
AA 97 (97%) a 132 (84.6%) a 81 (87%) a 51 (81%) a
Ac 3 (3%) a 24 (15.4%) b 12 (13%) b 12 (19%) b
Single allele
A 197 (98.5%) a 288 (92.3%) a 174 (93.5%) a 114 (90.4%) a
c 3 (1.5%) a 24 (7.7%) b 12 (6.5%) b 12 (9.6%) b
Note: Different symbols indicate statistical significance (P  0.005).
Abbreviations: TPg, total patient group; DM, diabetes mellitus; nDM, nondiabetes mellitus.Vascular Health and Risk Management 2010:6 14
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that coronary artery disease (CAD) was coexistent with 
PAOD although not present in a control group.
Although the results of this study agree with those of 
Schgoer and colleagues,16 they are at odds with the results 
of Gaetani and colleagues14 as they found no statistically 
significant difference between the control group and PAOD 
patients regarding IHD.
In the present work, there were statistically significant 
differences for a family history of diabetes mellitus or 
hypertension between the control group versus TPG and 
DM patients, however, there was no statistical significant 
difference between controls versus NDM patients. This is 
in agreement with the case controls study of Pradhan and 
colleagues.18
We also determined there was a statistically significant 
difference between the control group and diabetic patients 
regarding cholesterol and for triglycerides between control 
group and the TPG. These results are in agreement with 
Iwashima and colleagues,19 though they disagreed with those 
of Mueller and colleagues.18 Regarding high-density lipopro-
tein (HDL) and low-density lipoprotein (LDL) there were 
significant differences between control versus TPG patients, 
results that were in agreement with those of both Iwashima 
and colleagues and Bergmark and colleagues.19,20
In the present study it was determined that no statistically 
significant (P  0.05) difference existed between the control 
group and the TPG regarding the AA genotype of E-selectin 
although there was a statistically significant difference regard-
ing AC genotype. These results are in agreement with those 
reported by Li and colleagues,21 who found the distribution of 
the AA and AC genotypes were 93.8% and 6.2% in the control 
subjects, respectively and 86.7% and 13.3% in patients with 
CAD, respectively. In the study of Yoshida and colleagues,8 
the frequency of Arg128-positive was significantly higher 
in patients than in the controls (12.6% versus 6.7%). They 
concluded that the E-selectin Ser128Arg polymorphism 
can functionally alter leukocyte-endothelial interactions as 
well as biochemical and biological consequences, which 
may account for the pathogenesis of myocardial infarction. 
However, these results contrary to those of Endler and 
colleagues22 who found no significant differences within 
the genotype distribution of E-selectin S128R polymorphism 
when comparing patients with CAD to patients without CAD. 
In this study there was no statistically significant difference 
among the different groups regarding the A allele although 
was a significant difference among the different groups 
regarding C allele when compared with controls. Similar 
results were obtained by both Iwashima and colleagues and 
Meru and colleagues.19,23 Moreover, Wenzel and colleagues24 
reported an allele frequency of the S128R polymorphism to be 
91.3% S and 8.7% R in an control population and 84.5% S 
and 15.5% R in patients with severe coronary heart disease 
(CHD) and that the R128 allele was significantly more com-
mon in patients with CHD than in the controls.
Allele distribution was significantly different between 
our two groups: the E/K-allele ratio was 1.2 in the PAOD 
group and 0.43 in controls. The frequency of the K-allele 
was significantly higher for control group than TPG patients, 
while the frequency of the E-allele was significantly higher for 
TPG patients than control group. These results are in harmony 
with other researchers14,25 who found the frequency of the 
EE genotype in patients with PAOD was significantly higher 
than in controls, while the frequency of the KK genotype 
was significantly higher in control subjects. The results of 
Yokoyama and colleagues26 found that the distribution of 
K469E polymorphism in type 2 DM and control subjects was 
not significantly different between both groups results that are 
in conflict to our findings although such a difference may be 
due to differences in the selection of PAOD patients.
In the present work we found no statistical difference 
between the different polymorphisms and the clinical history 
and laboratory data among the patient groups except in those 
with IHD, where there was significant difference between 
EE and EK (6.2% vs 3.2%). These results are in accordance, 
in part, with those of Milutinovic and Petrovic27 who found 
no statistically significant association between the genotypes 
and coronary risk factors (clinical history and laboratory).
When comparing the E-selectin and ICAM-1 genotypes 
with regards to the site of occlusion in the TPG, we found 
there was no significant association between different groups. 
We also found that the incidence of SFA, amongst the TPG, 
Table 5b genotype and allele of icAM in patients and control
Variables Groups
  Control 
(n = 100)
TPG  
(n = 156)
DM 
(n = 3)
NDM 
(n = 63)
ICAM
ee 13 (13%) a 48 (30.8%) b 27 (29%) b 21 (33.3%) b
KK 53 (53%) a 33 (21.2%) b 21 (22.6%) b 12 (19%) b
eK 34 (34%) a 75 (48%) b 45 (48.4%) b 30 (47.7%) b
Single allele
K 140 (70%) a 141 (45.2%) b 87 (46.8%) b 54 (42.8%) b
e 60 (30%) a 171 (54.8%) b 99 (53.2%) b 72 (57.2%) b
Note: Different symbols indicate significance.
Abbreviations: icAM, intercellular adhesion molecule;   TPg, total patient group; 
DM, diabetes mellitus; nDM, nondiabetes mellitus.Vascular Health and Risk Management 2010:6
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was the most common form of occlusion, results that are in 
accordance with Meru and colleagues.23
We evaluated the concurrent E-selectin and ICAM-1 
genotypes in patients with PAOD with a normal control group 
and observed no significant association between AC and EE 
genotypes. However, we did find the concurrent association 
of the AC genotype in the E-selectin gene and EE genotype 
of ICAM-1 gene in 24 TPG patients. These data support the 
hypothesis that E-selectin and ICAM-1 are important in the 
pathophysiology of vascular diseases and suggest a role for 
anti-inflammatory therapy in the prevention and treatment 
PAOD.
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